Tetanus toxoid - medicine shortage information

Back to ALL shortages and discontinuations    Back to CRITICAL shortages and discontinuations

If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.

More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub

Product details Supply Impact Dates Further Details
NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent syringe
AUST R: 199742
Active ingredients:
Meningococcal polysaccharide group A
Meningococcal polysaccharide group C
Meningococcal polysaccharide group W135
Meningococcal polysaccharide Group Y
Tetanus toxoid

Dosage form:
Injection, powder for

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

From
08 Jun 2026
to
26 Jun 2026

Shortage status:
Current

Availability:
Only available under NIP or government programs

Reason:
Manufacturing

Management action:
The sponsor is working to expedite the next shipment and is closely controlling supply. Alternative brands are available.
ADT BOOSTER diphtheria and tetanus vaccine adsorbed suspension for injection syringe
AUST R: 130919
Active ingredients:
Diphtheria toxoid
Tetanus toxoid

Dosage form:
Injection, suspension

Sponsor:
Seqirus Pty Ltd

Phone:
1800642035

From
23 Mar 2026
to
30 Apr 2026

Shortage status:
Resolved

Availability:
Available

Reason:
Transport / Logistic issues / Storage capacity issues
NEISVAC-C VACCINE meningococcal group c polysaccharide conjugate vaccine suspension for injection syringe
AUST R: 83093
Active ingredients:
Meningococcal polysaccharide group C
Tetanus toxoid

Dosage form:
Injection, suspension

Sponsor:
Pfizer Australia Pty Ltd

Phone:
1800 675 229

Deletion from market:
01 Jul 2025

Shortage status:
Discontinued

Availability:
Reduction in supply until supply is exhausted

Reason:
Commercial Changes / Commercial viability

Management action:
Reduction in supply until supply is exhausted. Patients are advised to consult their health professional to discuss alternative options.